JPRN-C000000378已完成未知
A combination of methylprednisolone and prednisolone and a combination of Methylprednisolone, prednisolone and mizoribine for systemic lupus erythematosus in children: A randomized controlled trial of efficacy and safety izolibin for (JSRDC04) - A combination of methylprednisolone and prednisolone and a combination of methylprednisolone, prednisolone and mizoribine: A randomized controlled trial (JSRDC04)
Japanese Study Group of Renal Disease in Children(JSRDC)0 个研究点目标入组 60 人开始时间: 2006年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2years-old 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Chronic rheumatoid arthritis, diffuse scleroderma or dermatomyositis. 2.History of immunosuppressive drugs administration. 3.Medical history of allergy or hypersensitivity reactions to mizoribine. 4.Poorly controlled hypertension. 5.Active infectious disease. 6.Severe liver disfunction. 7.Pregnancy. 8.Judged inappropriate for this study by the physicians.
研究者
相似试验
已完成
不适用
Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06)Steroid-sensitive nephrotic syndromeJPRN-C000000379Japanese Study Group of Renal Disease in Children(JSRDC)50
已完成
2 期
Combination therapy of melphalan plus prednisolone and zoledronic acid for untreated multiple myeloma patients ineligible for autologous stem cell transplantatioMultiple MyelomaJPRN-UMIN000001435Myeloma Bone Disease Study Group130
招募中
2 期
To evaluate the adjuvant potential of methotrexate in mucosal/ limited mucocutaneous pemphigus vulgarisCTRI/2018/07/015002PGIMER
进行中（未招募）
不适用
Mental disability often occurs after cardiac surgery, which may be due to inflammation of the brain. Prophylactic cortisone treatment may suppress the brain inflammation and reduce the degree of mental disability after cardiac surgery.EUCTR2012-004232-37-SESahlgrenska Universtitetssjukhuset/SUS
已完成
不适用
A combination of prednisolone and mizoribine and a combination of prednisolone, mizoribine, warfarin and dipyridamole for IgA nephropathy with diffuse mesangial prolideration in children:A randomized controlled trial of efficacy and safetyIgA nephropathy in childrenJPRN-C000000363The Japanese Pediatric IgA Nephropathy of Treatment Study Group80